119 related articles for article (PubMed ID: 38271732)
1. PSMA PET/CT as a predictive tool for subregional importance estimates in the parotid gland.
Sample C; Rahmim A; Benard F; Wu J; Clark H
Biomed Phys Eng Express; 2024 Feb; 10(2):. PubMed ID: 38271732
[No Abstract] [Full Text] [Related]
2. Heterogeneous PSMA ligand uptake inside parotid glands.
Sample CM; Uribe C; Rahmim A; Bénard F; Wu J; Clark H
Phys Med; 2024 May; 121():103366. PubMed ID: 38657425
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Dose response modelling of secretory cell loss in salivary glands using PSMA PET.
Mohan V; Bruin NM; Steenbakkers RJHM; Noordzij W; Terhaard CHJ; de Keizer B; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
Radiother Oncol; 2022 Dec; 177():164-171. PubMed ID: 36368471
[TBL] [Abstract][Full Text] [Related]
5. The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function.
Li JF; Qin LP; Wu QY; Guo XH; Yang JZ; Wan QC; Cheng MH; Xie LJ
Clin Rheumatol; 2022 May; 41(5):1543-1550. PubMed ID: 35089469
[TBL] [Abstract][Full Text] [Related]
6. Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y; Lee MT; Jameson MG; Chlap P; Keall P; Moses D; Lin P; Fowler A
Radiother Oncol; 2023 Sep; 186():109745. PubMed ID: 37330056
[TBL] [Abstract][Full Text] [Related]
7. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
[TBL] [Abstract][Full Text] [Related]
8. Combined model-based and patient-specific dosimetry for
Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
[TBL] [Abstract][Full Text] [Related]
9. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
10. The tubarial salivary glands: A potential new organ at risk for radiotherapy.
Valstar MH; de Bakker BS; Steenbakkers RJHM; de Jong KH; Smit LA; Klein Nulent TJW; van Es RJJ; Hofland I; de Keizer B; Jasperse B; Balm AJM; van der Schaaf A; Langendijk JA; Smeele LE; Vogel WV
Radiother Oncol; 2021 Jan; 154():292-298. PubMed ID: 32976871
[TBL] [Abstract][Full Text] [Related]
11. Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT.
Gühne F; Drescher R; Aschenbach R; Seifert P; Freesmeyer M
Tomography; 2020 Sep; 6(3):288-289. PubMed ID: 32879898
[TBL] [Abstract][Full Text] [Related]
12. Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics.
Wilkie JR; Mierzwa ML; Casper KA; Mayo CS; Schipper MJ; Eisbruch A; Worden FP; El Naqa I; Viglianti BL; Rosen BS
Radiother Oncol; 2020 Jul; 148():30-37. PubMed ID: 32311598
[TBL] [Abstract][Full Text] [Related]
13. Effect of External Cooling on
Yilmaz B; Nisli S; Ergul N; Gursu RU; Acikgoz O; Çermik TF
J Nucl Med; 2019 Oct; 60(10):1388-1393. PubMed ID: 30850503
[TBL] [Abstract][Full Text] [Related]
14. Assessment of 18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters for reference standard organs: Inter-reader, inter-modality, and inter-patient variability.
Lawrence EM; Kieler M; Cooley G; Wells SA; Cho SY
PLoS One; 2023; 18(4):e0283830. PubMed ID: 37023049
[TBL] [Abstract][Full Text] [Related]
15. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
17. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses.
Aksu A; Vural Topuz Ö; Yılmaz G; Çapa Kaya G; Yılmaz B
Ann Nucl Med; 2022 Mar; 36(3):310-318. PubMed ID: 34988888
[TBL] [Abstract][Full Text] [Related]
18. Metabolic imaging biomarkers of postradiotherapy xerostomia.
Cannon B; Schwartz DL; Dong L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study.
Harsini S; Saprunoff H; Alden T; Mohammadi B; Wilson D; Bénard F
J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167
[TBL] [Abstract][Full Text] [Related]
20. Physiological PSMA Uptake in the Tubarial Salivary Glands and Its Implications in the PARIS Protocol-A First Study of Its Kind!
Sakthivel P; Thakar A; Arunraj ST; Prashanth A; Kumar R; Sharma SC; Kumar R
Clin Nucl Med; 2021 Aug; 46(8):e398-e405. PubMed ID: 33782285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
